ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases

NCT05062317 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Liver Metastases

Interventions

DRUG: Leucovorin
DRUG: 5-FLUOROURACIL
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Capecitabine
DRUG: Bevacizumab

Sponsor

M.D. Anderson Cancer Center